Alternative Biomarkers for Combined Biology
- Authors
- Kim, Yong-Hyun; Kirsop, Jennifer; Tang, Wai Hong Wilson
- Issue Date
- 4월-2017
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- Chemotherapy-related cardiac dysfunction; Heart failure; Malignancy; Biomarkers
- Citation
- HEART FAILURE CLINICS, v.13, no.2, pp.381 - +
- Indexed
- SCIE
SCOPUS
- Journal Title
- HEART FAILURE CLINICS
- Volume
- 13
- Number
- 2
- Start Page
- 381
- End Page
- +
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/83969
- DOI
- 10.1016/j.hfc.2016.12.009
- ISSN
- 1551-7136
- Abstract
- Chemotherapy-related cardiac dysfunction (CRCD) has challenged clinicians to hesitate in using cardiotoxic agents such as anthracycline and several protein kinase inhibitors. As early detection of CRCD and timely cessation of cardiotoxic agents became a strategy to avoid CRCD, cardiac troponin and natriuretic peptide are measured to monitor cardiotoxicity; however, there are inconsistencies in their predictability of CRCD. Alternative biomarkers have been researched extensively for potential use as more sensitive and accurate biomarkers. The mechanisms of CRCD and previous studies on traditional and novel biomarkers for CRCD are examined to enlighten future direction of investigation in this combined biology.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.